You are looking for

Most Europeans born today will live into their eighties but behind that impressive statistic lie inequalities and ill-health. It’s time we focused on adding life to years instead of years to life. In 1990, life expectancy at birth was 74.1 years in Europe. Today, it’s 80.9. This is a remarkable achievement, by any measure. However, […]

Artificial intelligence technology can help to meet rising demand for early detection of melanoma. Skin cancer and melanoma (the most severe type of skin cancer) are becoming a social health issue. The incidence has been rising. Currently, between 2 and 3 million non-melanoma skin cancers and 132,000 melanoma skin cancers occur globally each year.  Experts […]

My name is Isabel Saraiva. I’m Portuguese and ex-smoker. I quit smoking in April 2006 when I was diagnosed with COPD, Chronic Obstructive Pulmonary Disease. COPD is a progressive respiratory disease characterized by the obstruction of lung airflow making breathing difficult. Prevention, which means quitting smoking and access to early diagnostic, is the most important […]

This time last year, I wrote a blogpost about the priorities MedTech Europe would be working on in 2014. This year, I’ve decided to take a different approach. Based on what I see, hear and read every day, I’ll outline what I believe to be the major medtech trends, topics and evolutions we’ll be talking […]

Can MedTech compete in globalised markets? Here’s a selection of five leading views on healthcare consumarisation.
The lure of wearable technology and its application to health is tremendous- so tremendous that even the richest company on the planet-Apple, can’t resist it apparently. And so goes the recent insider news that has captured the attention of people worldwide “Apple is developing software and sensors that can predict heart attacks”. Not so fast Apple, not so fast….

Mobile health solutions for collecting patient data via communicating medical devices are opening new possibilities for remote monitoring and management of individuals suffering from chronic illnesses. At the same time, the ‘quantified self’ has gained increasing mass market appeal through the availability of personal, connected devices that can track human physical activity.  These are resulting […]

In their latest study, “Access to Quality Medicines and Medical Devices for Diabetes Care in Europe”, the International Diabetes Federation Europe conducted a survey on the challenges people with diabetes are facing when seeking access to diabetes treatment.
The IDF Europe outlined several of these challenges in the blog post “Improving access to medical technologies for diabetes care in Europe”, including limited access to information and education used for managing the disease. We would like to thank MedTech Europe for giving us this opportunity to share our insights and our approach on the accessibility of medical technology.

“Nihil novi sub sole” said the Vulgate. That could not be farther from reality when it comes to the MedTech Europe blog. And I am privileged to be the first author to “lay pen to paper” and contribute to MedTech Views, an initiative by MedTech Europe to establish a true platform for dialogue about medical technologies. No priority is given to any one healthcare stakeholder, and everyone has the opportunity to submit their view as we strive to have an open exchange of opinions on the new platform.

Does Europe have a proper start-up culture? Are we doing enough for young professionals? According to Neelie Kroes, Vice-President of the European Commission, in her article for the World Economic Forum, we could do more to make Europe fertile ground for start-ups, and engage the youngest generation entering the workforce. As a young professional in Brussels well-acquainted with millennial woes, I was eminently interested in the views of an established and influential official at the European Union.